Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.16B |
| 2 |
Bank of America
BAC
|
+$855M |
| 3 |
Comcast
CMCSA
|
+$620M |
| 4 |
Amazon
AMZN
|
+$505M |
| 5 |
Micron Technology
MU
|
+$486M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Goldman Sachs
GS
|
+$441M |
| 2 |
Palo Alto Networks
PANW
|
+$300M |
| 3 |
Verizon
VZ
|
+$286M |
| 4 |
Fidelity National Information Services
FIS
|
+$285M |
| 5 |
Stanley Black & Decker
SWK
|
+$244M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 6.22% |
| 2 | Financials | 6.16% |
| 3 | Industrials | 5.09% |
| 4 | Consumer Discretionary | 4.89% |
| 5 | Healthcare | 4.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CDK
2151
CALL
DELISTED
CDK Global, Inc.
CDK
| $5.9M | ﹤0.01% |
82,800
-38,600
| -32% | -$2.59M |
|
2152
PUT
AstraZeneca
AZN
$243B
| $5.9M | ﹤0.01% |
85,000
+6,100
| +8% | +$411K |
|
2153
Penumbra
PEN
$12.9B
| $5.9M | ﹤0.01% |
62,679
-61,120
| -49% | -$6.06M |
|
|
PPLI
2154
CALL
People Inc
PPLI
$3.01B
| $5.89M | ﹤0.01% |
269,699
-83,931
| -24% | -$1.88M |
|
2155
PUT
DXC Technology
DXC
$1.72B
| $5.89M | ﹤0.01% |
71,788
+52,714
| +276% | +$4.26M |
|
2156
PUT
Avery Dennison
AVY
$13.6B
| $5.89M | ﹤0.01% |
51,300
+34,400
| +204% | +$3.72M |
|
|
MOMO
2157
Hello Group
MOMO
$850M
| $5.88M | ﹤0.01% |
240,388
-405,580
| -63% | -$11.7M |
|
2158
CALL
Global X Lithium & Battery Tech ETF
LIT
$1.61B
| $5.88M | ﹤0.01% |
151,600
+129,500
| +586% | +$5.09M |
|
2159
PetMed Express
PETS
$38.9M
| $5.88M | ﹤0.01% |
129,151
+9,368
| +8% | +$369K |
|
2160
PUT
Chubb
CB
$133B
| $5.87M | ﹤0.01% |
40,200
+1,600
| +4% | +$239K |
|
|
BITA
2161
DELISTED
Bitauto Holdings Limited
BITA
| $5.87M | ﹤0.01% |
184,626
+178,808
| +3,073% | +$7.29M |
|
2162
Applied Industrial Technologies
AIT
$13.4B
| $5.87M | ﹤0.01% |
+86,190
| New | +$5.48M |
|
2163
CALL
Cleveland-Cliffs
CLF
$6.79B
| $5.87M | ﹤0.01% |
814,200
+30,800
| +4% | +$205K |
|
2164
Rhythm Pharmaceuticals
RYTM
$7.95B
| $5.87M | ﹤0.01% |
+201,828
| New | +$5.34M |
|
2165
PUT
Advanced Energy
AEIS
$13.2B
| $5.86M | ﹤0.01% |
86,800
+71,900
| +483% | +$5.79M |
|
2166
PUT
Nexstar Media Group
NXST
$5.84B
| $5.85M | ﹤0.01% |
74,800
+34,200
| +84% | +$2.3M |
|
|
SHPG
2167
CALL
DELISTED
Shire pic
SHPG
| $5.85M | ﹤0.01% |
37,700
-7,700
| -17% | -$1.14M |
|
2168
Nike
NKE
$60.4B
| $5.84M | ﹤0.01% |
93,396
-280,722
| -75% | -$16.1M |
|
|
MTOR
2169
DELISTED
MERITOR, Inc.
MTOR
| $5.83M | ﹤0.01% |
248,428
+27,813
| +13% | +$698K |
|
2170
iShares Emerging Markets Equity Factor ETF
EMGF
$1.91B
| $5.82M | ﹤0.01% |
117,679
+90,590
| +334% | +$4.38M |
|
2171
PUT
Ventas
VTR
$46.9B
| $5.82M | ﹤0.01% |
97,000
+53,300
| +122% | +$3.37M |
|
2172
iShares Global Energy ETF
IXC
$2.77B
| $5.82M | ﹤0.01% |
+163,715
| New | +$5.62M |
|
2173
CALL
New Oriental
EDU
$8.36B
| $5.82M | ﹤0.01% |
61,900
+11,000
| +22% | +$976K |
|
2174
ConocoPhillips
COP
$152B
| $5.81M | ﹤0.01% |
105,833
+45,841
| +76% | +$2.36M |
|
2175
WisdomTree International Equity Fund
DWM
$694M
| $5.81M | ﹤0.01% |
104,126
+64,496
| +163% | +$3.55M |
|
Similar funds
Ken Griffin's Q4 2017 Portfolio in Review
As of Q4 2017, Ken Griffin held 8,908 positions worth $164B, up 26% from $130B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Ken Griffin deployed $21.1B of net new capital in Q4 2017, opening 1,440 new positions and adding to 3,569 existing holdings. Its largest new stake was Celgene Corp: 3,708,916 shares worth $387M.
By sector, the portfolio is most concentrated in Technology at 6.2% of assets, down from 7.2% a quarter earlier, followed by Financials and Industrials.
On the sell side, the largest reduction was Goldman Sachs, an estimated $441M trimmed.
- Ken Griffin's largest Q4 2017 buy was Celgene Corp: 3,708,916 shares worth $387M.
- Ken Griffin added most to State Street SPDR S&P 500 ETF Trust in Q4 2017, an estimated $1.16B increase.
- Ken Griffin's biggest Q4 2017 reduction was Goldman Sachs, cutting an estimated $441M.
- Ken Griffin fully exited CR Bard Inc. in Q4 2017, selling an estimated $209M.
- Ken Griffin's ten largest holdings make up 19% of its $164B portfolio in Q4 2017.
- Ken Griffin opened 1,440 new positions and closed 988 in Q4 2017.
- Ken Griffin's portfolio value rose 26% quarter-over-quarter to $164B.
Based on Citadel Advisors's 13F filing for Q4 2017, filed 9 Feb 2018.